No CrossRef data available.
Article contents
EPA-0048 - Relationships Between Serum Total Antioxidant Capacity and Typical/atypical Antipsychotic Treatment in Acute Paranoid Schizophrenia
Published online by Cambridge University Press: 15 April 2020
Abstract
Schizophrenia is a chronic disease characterized by disturbances of thought, perception, volition, affectivity and cognition. An imbalance of the oxidant-antioxidant system is one of the proposed etiological factors. There are controversies regarding the effect of antipsychotics on the oxidant-antioxidant balance.
The aim of this research is to study the serum levels of the total antioxidant capacity (TAC) in paranoid schizophrenia patients treated with typical and/or atypical antipsychotics.
The sample is comprised by 38 patients admitted to the psychiatric ward of the University Hospital of the Canary Islands. All patients met DSM-IV criteria for paranoid schizophrenia. Some patients were treated only with atypical antipsychotics (N=21) while others were treated with a combination of atypical and typical antipsychotics (N=17).
The next table shows the comparison of serum TAC levels at admission (TAC-A) and discharge (TAC-D) at 12:00 and 00:00 h.
Antipsychotics | Mean | S.D | P | |
---|---|---|---|---|
TAC-A-12 | Only Atypical | 0.6633 | 0.14215 | 0.952 |
Typical+Atypical | 0.6604 | 0.14889 | ||
TAC-A-00 | Only Atypical | 0.6004 | 0.15062 | 0.626 |
Typical+Atypical | 0.6247 | 0.16163 | ||
TAC-D-12 | Only Atypical | 0.6070 | 0.16067 | 0.019 |
Typical+Atypical | 0.7172 | 0.07654 | ||
TAC-D-00 | Only Atypical | 0.6001 | 0.16171 | 0.153 |
Typical+Atypical | 0.6836 | 0.07842 |
Patients treated with a combination of typical and atypical antipsychotics present at discharge (12:00 hours) significantly higher levels of TAC than patients treated only with typical antipsychotics. The remaining comparisons did not elicit significant results.
The results point out the fact that a combination of typical and atypical antipsychotics is more helpful in reducing the deficits of the antioxidant system than treatments based only on typical antipsychotics.
- Type
- EPW01 - Schizophrenia 1
- Information
- Copyright
- Copyright © European Psychiatric Association 2014
Comments
No Comments have been published for this article.